Variable expression of lineage regulators in differentiated stromal cells indicates distinct mechanisms of differentiation towards common cell fate

Gene

Volumn 533, Issue 1, 2014, Pages 173-179

  Jääger, Kersti ^a,b   Fatkina, Angelika ^b   Velts, Anna ^b   Orav, Ester ^b   Neuman, Toomas ^a,c  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b Cellin Technologies LLC   (Estonia)

^c Protobios LLC   (Estonia)

Author keywords

Cell to cell variation; Differentiation; Gene expression; Stromal cells

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MARKER GENE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; RNA ISOLATION; SKIN; STROMA CELL; SUBCUTANEOUS FAT;

AB; ACAN; ADIPONECTIN; ADIPOSE-DERIVED MESENCHYMAL STEM CELL; ADMSC; AGGRECAN; ALCIAN BLUE; ALIZARIN RED S; ALKALINE PHOSPHATASE; ALP; APN; ARS; C/EBP; CCAAT/ENHANCER-BINDING PROTEIN; CELL-TO-CELL VARIATION; COL II; COLLAGEN TYPE II; DIFFERENTIATION; FABP4; FATTY ACID-BINDING PROTEIN 4; FB; FIBROBLAST; GENE EXPRESSION; OIL RED O; ORO; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; PPARΓ; STROMAL CELLS;

CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84887219934     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.094     Document Type: Article

References (36)

1. Aigner T., Gebhard P.M., Schmid E., Bau B., Harley V., Pöschl E. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol. 2003, 22:363-372.
2. Bae S., et al. Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res. 2009, 335:565-573.
3. Banerjee C., et al. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 1997, 66:1-8.
4. Bi W., Deng J.M., Zhang Z., Behringer R.R., De Crombrugghe B. Sox9 is required for cartilage formation. Nat. Genet. 1999, 22:85-89.
5. Blasi A., et al. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vascular Cell 2011, 3:5.
6. Da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
7. Dominici M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
8. Franceschi R.T., Ge C., Xiao G., Roca H., Jiang D. Transcriptional regulation of osteoblasts. Cells Tissues Organs 2009, 189:144-152.
9. Frith J., Genever P. Transcriptional control of mesenchymal stem cell differentiation. Transfus Med Hemother 2008, 35:216-227. B. Bhushan (Ed.).
10. Gimble J., Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003, 5:362-369.
11. Gronthos S., Franklin D.M., Leddy H.a, Robey P.G., Storms R.W., Gimble J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 2001, 189:54-63.
12. Haniffa M., et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J. Immunol. 2007, 179:1595-1604.
13. Hanson S.E., et al. Characterization of mesenchymal stem cells from human vocal fold fibroblasts. Laryngoscope 2010, 120:546-551.
14. Ishii M., et al. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem. Biophys. Res. Commun. 2005, 332:297-303.
15. Jääger K., Neuman T. Human dermal fibroblasts exhibit delayed adipogenic differentiation compared with mesenchymal stem cells. Stem Cells Dev. 2011, 20:1327-1336.
16. Jääger K., Islam S., Zajac P., Linnarsson S., Neuman T. RNA-seq analysis reveals different dynamics of differentiation of human dermis- and adipose-derived stromal stem cells. PLoS One 2012, 7:e38833.
17. Kassis I., et al. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant. 2006, 37:967-976.
18. Kou I., Ikegawa S. SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J. Biol. Chem. 2004, 279:50942-50948.
19. Lee J.-H., Kemp D.M. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem. Biophys. Res. Commun. 2006, 341:882-888.
20. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., De Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 1997, 17:2336-2346.
21. Lefterova M.I., et al. PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22:2941-2952.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt method. Methods 2001, 25:402-408.
23. Lorenz K., et al. Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp. Dermatol. 2008, 17:925-932.
24. Mitchell J.B., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385.
25. Rosen E.D. The transcriptional basis of adipocyte development. Prostaglandins Leukot. Essent. Fat. Acids 2005, 73:31-34.
26. Schroeder T.M., Jensen E.D., Westendorf J.J. Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res. C Embryo Today 2005, 75:213-225.
27. Sekiya I., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 2000, 275:10738-10744.
28. Shao H.Y., Hsu H.Y., Wu K.S., Hee S.W., Chuang L.M.Y.J. Prolonged induction activates Cebpα independent adipogenesis in NIH/3T3 cells. PLoS One 2013, 8:e5145.
29. Toma J.G., et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 2001, 3:778-784.
30. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 8:1224-1234.
31. Wagner W., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 2005, 33:1402-1416.
32. Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., Haché R.J.G. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 2003, 22:2135-2145.
33. Zhao Q., Eberspaecher H., Lefebvre V., De Crombrugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 1997, 209:377-386.
34. Zhou G., Lefebvre V., Zhang Z., Eberspaecher H., De Crombrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 1998, 273:14989-14997.
35. Zuk P.A., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
36. Zuk P.A., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.